Logo1
ISLH - 2023 36th Annual International Symposium on Technical Innovations in Laboratory Hematology (PACE)
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV/technology.
Quality of facilities and facility accommodations.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
Objective 1: Define new technological developments in laboratory hematology testing
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
Objective 2: Implement technological advances in the routine hematology laboratory
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
Did this program improve your Skill or Strategy in your role or contribution as a member of the healthcare team?
If no, why not?
Do you believe your participation in this activity will positively impact your healthcare team?
If yes, how?
If no, why not?
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor used technology effectively
Understand the relevance of molecular studies in the new classifications of myeloid neoplasms
Understand the role of morphology not only in diagnosis but also in the initial progression detection of myeloproliferative neoplasms
The instructor used technology effectively
Understand the useful of peripheral blood samples for residual disease monitoring
The instructor used technology effectively
Describe the potential applications of red blood distribution width, monocyte distribution width, and other novel CBC parameters in human disease
Identify the differences that distinguish neonatal CBC reference ranges and other laboratory hematology findings from those of other pediatric populations and adults
Identify the role and rationale for whole genome sequencing in acute myeloid leukemia
The instructor used technology effectively
Review von Willebrand disease (VWD) subtypes and testing approaches
Discuss use of von Willebrand factor (VWF) activity/antigen testing ratios to discriminate type 1 and type 2 VWD
Understand the meaning of low VWF in relation to diagnose of VWD
The instructor used technology effectively
Applied Machine learning in hematopathology
immune differential counts
conventional Morphology still matters. tales told by vacuoles
The instructor used technology effectively
Describe the pathogenesis of heparin-induced thrombocytopenia, Vaccine-induced thrombocytopenia and spontaneous HIT.
Describe the history of ISLH and measures to control laboratory test utilization.
The instructor used technology effectively
Review of iron deficiency in patients with chronic inflammation and summary the relevance of laboratory findigns
The role of moprohlogic findings in the peripheral blood and bone marrow in myeloproliferative neoplasms
Discussion of the current epidemiology of anemia in developing countries and review of anemia controlling measures
The instructor used technology effectively
to cover updates in the newest hemepath classifications
The instructor used technology effectively
discuss interesting cases in coagulation testing
Review the laboratory workup of patients with coagulation disorders
Discuss best practices in laboratory medicine
The instructor used technology effectively
Review the history of regulation of laboratory tests in the U.S.
Discuss the pros and cons of additional regulation of laboratory developed tests
Define laboratory developed tests
The instructor used technology effectively
Understand the ICSH projects underway and the anticipated benefits for standardised test performance and reporting
Understand the considerations and tradeoffs necessary to operationalize AI in clinical flow cytometry.
Understand the latest Viscoelastic document from ICSH
The instructor used technology effectively
Understand current information on anticoagulant drug level assessment, including levels of new agent
Understand rare and challenging to diagnose bleeding disorders, and discuss strategies for their diagnosis
The instructor used technology effectively
understand current information on novel networks in myeloma uncovered by single cell sequencing
Understand the use of measuring factor II with PT vs. Ecarin reagents to diagnose vitamin K deficiency
The instructor used technology effectively
Discuss the recent developement in cellular analysis technology and flow cytometry
The application of new cellular markers from automated hematologic analyzers
Introduction of artificial neural network model for the screening of hematologic diseases
The instructor used technology effectively
Assesment of hypercoagubality using thromboelastometry
detection of factor Xa inhibitor drug using MRX PT DOAC assay
Charecterization an unusal hemoglobin variant (HB Hammersmith)
The instructor used technology effectively
To understand about development of neural network hematology review models using scatter plot features
The instructor used technology effectively
to emphasise importance of artificial nueral networks in hematology diagnosis
The instructor used technology effectively
Discuss coagulation results and their interpretation, using case-examples
The instructor used technology effectively
Understand the mechanisms involved in the origin of the sideroblastic anemias
The instructor used technology effectively
Understand molecualr basis of hemoglobin disorders, describe various methods for genetic testing of hemoglobin disorders, be able to recommend molecular testing when indicated
The instructor used technology effectively
Discuss genetic abnormalities that lead to platelet disorders and multimodal approach to diagnosis.
Understand the utility of NGS in the workup of platelet disorders
Discuss the diagnostic and prognostic utility of genetic testing, including NGS, for lymphoma
The instructor used technology effectively
Is Mass cytometry ready for clinical applications
Spectral Flow cytometry
The instructor used technology effectively
review the role of external quality assessment (EQA) in platelet testing.
describe the use of post analytical platelet EQA.
to discuss how molecular laboratory can be set up with limited resources especially for CML monitoring
Please tell us about any sessions you found particularly good or bad.
Please tell us about any objectives you feel we accomplished well or poorly.
Please tell us about any presenters you found particularly good or bad.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question
Provided by amedco